Camden Capital, LLC Merck & Co., Inc. Transaction History

Camden Capital, LLC

$896 Million
Q3 2024

A detailed history of Camden Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Camden Capital, LLC holds 14,903 shares of MRK stock, worth $1.48 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

14,903

Previous 11,579 28.71%

Holding current value

$1.48 Million

Previous $1.43 Million 18.07%

% of portfolio

0.19%

Previous 0.11%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $369,462 - $428,696	3,324 Added 28.71%	14,903 $1.69 Million
Q2 2024 Aug 06, 2024	SELL	$123.8 - $132.96 $244,876 - $262,994	-1,978 Reduced 14.59%	11,579 $1.43 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $308,126 - $359,035	-2,721 Reduced 16.72%	13,557 $1.79 Million
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $920,654 - $1 Million	9,190 Added 129.66%	16,278 $1.77 Million
Q3 2023 Nov 03, 2023	BUY	$102.95 - $114.33 $126,319 - $140,282	1,227 Added 20.93%	7,088 $729,000
Q2 2023 Aug 09, 2023	BUY	$108.61 - $118.38 $223,845 - $243,981	2,061 Added 54.24%	5,861 $676,000
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $29,852 - $33,309	290 Added 8.26%	3,800 $404,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $147,598 - $189,241	-1,688 Reduced 32.47%	3,510 $389,000
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $127,217 - $142,914	1,505 Added 40.75%	5,198 $448,000
Q2 2022 Aug 03, 2022	SELL	$83.49 - $94.64 $274,348 - $310,987	-3,286 Reduced 47.08%	3,693 $337,000
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $23,449 - $26,285	319 Added 4.79%	6,979 $573,000
Q4 2021 Feb 28, 2022	SELL	$72.28 - $90.54 $341,017 - $427,167	-4,718 Reduced 41.47%	6,660 $510,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $38,742 - $48,529	536 Added 4.94%	11,378 $872,000
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $196,833 - $216,467	2,746 Added 33.92%	10,842 $814,000
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $140,127 - $154,995	1,993 Added 32.66%	8,096 $630,000
Q1 2021 May 10, 2021	BUY	$68.86 - $81.11 $33,534 - $39,500	487 Added 8.67%	6,103 $471,000
Q4 2020 Feb 04, 2021	BUY	$71.77 - $79.65 $33,731 - $37,435	470 Added 9.13%	5,616 $459,000
Q3 2020 Oct 30, 2020	BUY	$73.18 - $82.95 $120,893 - $137,033	1,652 Added 47.28%	5,146 $427,000
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $15,633 - $17,788	-222 Reduced 5.97%	3,494 $270,000
Q1 2020 Apr 13, 2020	SELL	$63.36 - $87.82 $95,103 - $131,817	-1,501 Reduced 28.77%	3,716 $286,000
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $404,734 - $456,696	5,217 New	5,217 $474,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Merck & Co., Inc. Transaction History